Patient presents with a chief complaint of painful rash.  Onset of symptoms began approximately [number] days ago with a prodrome of burning, tingling, or itching sensation localized to the [affected dermatome, e.g., thoracic, ophthalmic, cervical].  The rash is currently characterized by erythematous, maculopapular lesions that have evolved into vesicles clustered in a dermatomal distribution consistent with Herpes Zoster (shingles).  The patient reports [pain level, e.g., mild, moderate, severe] pain described as [pain characteristics, e.g., burning, stabbing, electric].  Pain assessment using a numerical rating scale (NRS) is documented as [NRS score].  Lesions are present on the [specific location, e.g., left flank, right forehead].  No lymphadenopathy is noted.  The patient denies fever, chills, or malaise.  Medical history includes [relevant medical history, e.g., hypertension, diabetes, immunocompromise].  Current medications include [list current medications].  Allergies include [list allergies].  Physical examination reveals [detailed findings related to the rash, including size, distribution, and characteristics of lesions].  Diagnosis of Herpes Zoster is made based on clinical presentation and characteristic dermatomal distribution of the rash.  Differential diagnosis includes contact dermatitis, impetigo, and varicella.  Treatment plan includes antiviral therapy with [medication name and dosage, e.g., acyclovir 800mg five times daily for 7 days] to reduce viral shedding, duration of symptoms, and risk of postherpetic neuralgia.  Pain management is addressed with [pain management plan, e.g., over-the-counter analgesics, prescription pain medication].  Patient education provided regarding contagious nature of the virus, proper hygiene, and potential complications such as postherpetic neuralgia.  Follow-up appointment scheduled in [timeframe] to assess treatment response and monitor for complications.  ICD-10 code B02.